Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 489
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06996288 | A Multicenter Randomized Controlled Clinical Trial of the Impact of Minimally Invasive Abdominal Surgery Esophageal Pressure Monitoring Guided Individualized PEEP on Postoperative Pulmonary Complications in Obese Patients | ||
| NCT05828875 | A Multicenter, Cross-sectional Study on the Quality of Life in Long-term Survival Esophageal Cancer Patients After Radical Radiochemotherapy/Radiotherapy | ||
| NCT05842018 | Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors) | ||
| NCT05507606 | Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations | ||
| NCT03664843 | Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients | ||
| NCT05908747 | Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer | ||
| NCT06143735 | A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors | ||
| NCT04836728 | Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer | ||
| NCT06760364 | A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer | ||
| NCT07254416 | A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients | ||
| NCT06208436 | The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer | ||
| NCT06951997 | QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer | ||
| NCT06867432 | Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma | ||
| NCT04842526 | Efficacy and Safety of Anlotinib, Irinotecan and Temozolomide in the Treatment of Refractory or Recurrent Neuroblastoma in Children: an Open, Single Arm, Single Center, Phase II Clinical Study | ||
| NCT06259058 | Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer | ||
| NCT06136026 | Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer | ||
| NCT06954558 | A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor | ||
| NCT04982939 | Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer | ||
| NCT06997302 | A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal Malignancies | ||
| NCT02191475 | Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock | ||
| NCT05085626 | Fluzoparib in Combination With Chidamide or Camrelizumab for HRD Positive HER2 Negative Advanced Breast Cancer | ||
| NCT05560308 | Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy | ||
| NCT07244874 | Sac-TMT Combined With Toripalimab for First-line Treatment of PD-L1 Positive a/mTNBC | ||
| NCT02405676 | BNHL-2015 for Children or Adolescents in China | ||
| NCT07272291 | A Phase II Study of Toripalimab Plus Chemotherapy and Low-Dose Radiotherapy for Neoadjuvant Therapy-Refractory Esophageal Squamous Cell Carcinoma | ||
| NCT02356276 | Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2 | ||
| NCT02207335 | Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer | ||
| NCT04553887 | Almonertinib as Upfront Treatment for Uncommon EGFR Mutation Harboring Non-Small-Cell Lung Cancer Patients: A Multicenter, Open-Label, Phase II Trial | ||
| NCT06454435 | Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer | ||
| NCT05025033 | Chemotherapy Combined With Apatinib and PD-1 Antibody | ||
| NCT05997147 | A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma | ||
| NCT03355612 | XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma | ||
| NCT04389177 | Pembrolizumab Plus Paclitaxel, Cisplatin Followed by Surgery for Locally Advanced ESCC (KEYSTONE-001) | ||
| NCT05036798 | Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System. | ||
| NCT07119931 | A Clinical Study Evaluating HAIC Combined With Iparomlimab and Tuvonralimab Injection Plus Bevacizumab in Patients With Initially Potentially Resectable Hepatocellular Carcinoma (ITBHaic Study) | ||
| NCT05236582 | Herombopag for Chemotherapy-induced Thrombocytopenia | ||
| NCT06563245 | Brentuximab Vedotin for Newly Diagnosed CHL in Chinese CAYA Based on PET/CT Assessment | ||
| NCT06828718 | The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC） | ||
| NCT06289062 | Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer | ||
| NCT05029973 | HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC | ||
| NCT04030845 | Patient Report Outcome-Reconstruction and Oncoplastic Cohort | ||
| NCT06452602 | Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC. | ||
| NCT06375486 | Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）. | ||
| NCT06717022 | A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors | ||
| NCT01660399 | Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy | ||
| NCT03880695 | Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma | ||
| NCT02774200 | A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients. | ||
| NCT05812495 | Minimally Invasive Intrathoracic Esophagogastric Side to Side Anastomosis vs. End to Side Anastomosis | ||
| NCT04250324 | Study of Safety and Efficacy of BZ019 in (R/R) Large B-cell Lymphoma | ||
| NCT06560528 | Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression |
